Related references
Note: Only part of the references are listed.Genome-wide pharmacogenomic analysis of the response to interferon β therapy in multiple sclerosis
Esther Byun et al.
ARCHIVES OF NEUROLOGY (2008)
Interferon-β increases BAFF levels in multiple sclerosis:: implications for B cell autoimmunity
M. Krumbholz et al.
BRAIN (2008)
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
Marco Prinz et al.
IMMUNITY (2008)
Relationship between MRI lesion activity and response to IFN-β in relapsing-remitting multiple sclerosis patients
J. Rio et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
TAM receptors are pleiotropic inhibitors of the innate immune response
Carla V. Rothlin et al.
CELL (2007)
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients
T. C. T. M. van der Pouw Kraan et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis:: A preliminary study
Alireza Minagar et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Selective blockade of the inhibitory Fcγ receptor (Fcγ RIIB) in human dendritic cells and monocytes induces a type I interferon response program
Kavita M. Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Sensitization to TLR7 agonist in IFN-β-preactivated dendritic cells
Martina Severa et al.
JOURNAL OF IMMUNOLOGY (2007)
CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE
Samantha L. Bailey et al.
NATURE IMMUNOLOGY (2007)
An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity
Emily C. Baechler et al.
MOLECULAR MEDICINE (2007)
Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients
C. Gneiss et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Innate immunity in multiple sclerosis: Myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response
Arnon Karni et al.
JOURNAL OF IMMUNOLOGY (2006)
A subtype of multiple sclerosis defined by an activated immune defense program
L. G. M. van Baarsen et al.
GENES AND IMMUNITY (2006)
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients
FK Tan et al.
RHEUMATOLOGY (2006)
Differential responsiveness to IFN-α and IFN-β of human mature DC through modulation of IFNAR expression
Martina Severa et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome
JE Gottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
J Río et al.
ANNALS OF NEUROLOGY (2006)
Downregulation of VLA-4 on T cells as a marker of long term treatment response to interferon beta-1a in MS
M Soilu-Hänninen et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Discovering statistically significant pathways in expression profiling studies
L Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Colon cancer prognosis prediction by gene expression profiling
A Barrier et al.
ONCOGENE (2005)
Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector
KJ Helbig et al.
HEPATOLOGY (2005)
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
FL Heppner et al.
NATURE MEDICINE (2005)
Transcription-based prediction of response to IFN beta using supervised computational methods
SE Baranzini et al.
PLOS BIOLOGY (2005)
Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells
EM Coccia et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon alfa immunotherapy
GB Lesinski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Coordinate overexpression of interferon-α-induced genes in systemic lupus erythematosus
KA Kirou et al.
ARTHRITIS AND RHEUMATISM (2004)
Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients
F Watzinger et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
BJ Barnes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Expression regulation and genomic organization of human polynucleotide phosphorylase, hPNPaseold-35, a Type I interferon inducible early response gene
M Leszczyniecka et al.
GENE (2003)
Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases
TA Stewart
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Analysis of gene, expression profiles in human systemic lupus erythematosus using oligonucleotide microarray
GM Han et al.
GENES AND IMMUNITY (2003)
Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon β:: Implications for clinical trials
J Río et al.
ANNALS OF NEUROLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens
N Kadowaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo
A Le Bon et al.
IMMUNITY (2001)